The worldwide landscape of renal treatment is shifting rapidly. With the global increase of Continual kidney condition (CKD), hypertension, and diabetes, the force on nephrology departments, specialised dialysis facilities, and transplant models has intensified significantly. For B2B companies—together with health-related product manufacturers of